Work

209 (PB197): Novel tumor microenvironment ameliorator E7130 shows substantial combination efficacy with enzalutamide in a preclinical model of castration-resistant prostate cancer.

Year: 2024

Type: article

Source: European Journal of Cancer

DOI: 10.1016/j.ejca.2024.114727

Authors: T. Abe, K. Ito, I. Benzaid, M.H. de Boisferon, Y. Kishi, B.A. Littlefield, O. Asano

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403763290

FWCI:

Cites:

Cited by:

Related to: 10